Last reviewed · How we verify

Methylcobalamin (methylB12) — Competitive Intelligence Brief

Methylcobalamin (methylB12) (Methylcobalamin (methylB12)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B12 supplement / Cobalamin. Area: Neurology; Hematology; Nutritional deficiency.

marketed Vitamin B12 supplement / Cobalamin Methionine synthase; methylmalonyl-CoA mutase cofactor Neurology; Hematology; Nutritional deficiency Small molecule Live · refreshed every 30 min

Target snapshot

Methylcobalamin (methylB12) (Methylcobalamin (methylB12)) — Arkansas Children's Hospital Research Institute. Methylcobalamin is an active form of vitamin B12 that serves as a cofactor for methionine synthase and other enzymes involved in DNA synthesis, myelin formation, and neurological function.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Methylcobalamin (methylB12) TARGET Methylcobalamin (methylB12) Arkansas Children's Hospital Research Institute marketed Vitamin B12 supplement / Cobalamin Methionine synthase; methylmalonyl-CoA mutase cofactor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B12 supplement / Cobalamin class)

  1. Arkansas Children's Hospital Research Institute · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Methylcobalamin (methylB12) — Competitive Intelligence Brief. https://druglandscape.com/ci/methylcobalamin-methylb12. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: